Clinical and prognostic impact of STAG2 mutations in myeloid neoplasms: the Mayo Clinic experience

Blood Adv. 2023 Apr 25;7(8):1351-1355. doi: 10.1182/bloodadvances.2022007937.
No abstract available

MeSH terms

  • Cell Cycle Proteins / genetics
  • Humans
  • Mutation
  • Myeloproliferative Disorders* / diagnosis
  • Myeloproliferative Disorders* / genetics
  • Neoplasms* / genetics
  • Prognosis

Substances

  • STAG2 protein, human
  • Cell Cycle Proteins